COVID-19 in the Dialysis Population – System Performance Data
Results
Among chronic dialysis patients in Ontario who have not had a COVID-19 infection in last 90 days, 46.6% had received a bivalent the COVID-19 booster by May 23, 2023. COVID-19 infection is determined by PCR testing, which is generally accessible to dialysis patients.
Why it matters
Individuals on chronic dialysis should stay up to date on COVID-19 boosters due to increased risk of infection and death.
Improving care in Ontario
We continue to track key metrics related to COVID-19 vaccinations among chronic dialysis patients.
Acknowledgements
We acknowledge that data used in this publication were from the Ontario Renal Reporting System, collected and provided by the Ontario Renal Network, a part of Ontario Health. We also acknowledge that data used in this publication was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health (MOH). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOH is intended or should be inferred.